Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 34% ± 14% | |
GABAergic neuron | 7 studies | 41% ± 19% | |
interneuron | 6 studies | 49% ± 19% | |
pericyte | 4 studies | 38% ± 16% | |
retinal cone cell | 4 studies | 53% ± 20% | |
retinal rod cell | 4 studies | 45% ± 20% | |
GABAergic interneuron | 3 studies | 45% ± 19% | |
astrocyte | 3 studies | 39% ± 13% | |
granule cell | 3 studies | 42% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 80% | 965.87 | 2125 / 2642 | 68% | 3.70 | 481 / 705 |
lung | 99% | 942.05 | 573 / 578 | 37% | 1.97 | 424 / 1155 |
thymus | 60% | 219.26 | 394 / 653 | 55% | 1.92 | 333 / 605 |
ovary | 73% | 428.63 | 131 / 180 | 34% | 1.18 | 145 / 430 |
skin | 58% | 182.42 | 1058 / 1809 | 28% | 0.93 | 133 / 472 |
adipose | 85% | 385.43 | 1020 / 1204 | 0% | 0 | 0 / 0 |
breast | 63% | 224.79 | 291 / 459 | 10% | 0.30 | 111 / 1118 |
blood vessel | 70% | 512.44 | 938 / 1335 | 0% | 0 | 0 / 0 |
kidney | 30% | 61.10 | 27 / 89 | 39% | 0.94 | 354 / 901 |
esophagus | 35% | 144.37 | 502 / 1445 | 27% | 1.17 | 49 / 183 |
spleen | 59% | 133.22 | 142 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 4.47 | 17 / 29 |
prostate | 51% | 136.61 | 125 / 245 | 5% | 0.08 | 23 / 502 |
uterus | 26% | 54.48 | 44 / 170 | 28% | 1.27 | 129 / 459 |
adrenal gland | 32% | 63.33 | 83 / 258 | 20% | 1.41 | 46 / 230 |
bladder | 33% | 80.67 | 7 / 21 | 9% | 0.31 | 45 / 504 |
tonsil | 0% | 0 | 0 / 0 | 38% | 1.20 | 17 / 45 |
heart | 30% | 101.33 | 256 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 29% | 94.08 | 274 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 0.44 | 16 / 80 |
pancreas | 4% | 5.75 | 12 / 328 | 12% | 0.31 | 21 / 178 |
intestine | 8% | 16.83 | 78 / 966 | 5% | 0.12 | 25 / 527 |
stomach | 5% | 11.09 | 17 / 359 | 5% | 0.13 | 14 / 286 |
liver | 0% | 0 | 0 / 226 | 4% | 0.33 | 18 / 406 |
muscle | 1% | 2.18 | 9 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007420 | Biological process | brain development |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0010468 | Biological process | regulation of gene expression |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0035063 | Biological process | nuclear speck organization |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007611 | Biological process | learning or memory |
GO_0032783 | Cellular component | super elongation complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0002151 | Molecular function | G-quadruplex RNA binding |
Gene name | AFF2 |
Protein name | AF4/FMR2 family member 2 (Protein FMR-2) (FMR2P) (Protein Ox19) |
Synonyms | OX19 FMR2 |
Description | FUNCTION: RNA-binding protein. Might be involved in alternative splicing regulation through an interaction with G-quartet RNA structure. . |
Accessions | ENST00000342251.7 [P51816-3] P51816 ENST00000370460.7 [P51816-1] ENST00000286437.7 [P51816-7] ENST00000370458.5 [P51816-4] ENST00000370457.9 [P51816-6] |